Copied


Hims & Hers Health (HIMS) Stock Price Prediction: analyst cuts meet a weak technical setup

Joerg Hiller   Nov 16, 2026 23:49 0 Min Read


Price action and what it says

HIMS traded at $19.12, near the low end of its daily range of $18.97 to $19.89. That keeps the stock just above immediate support at $18.76 and below the pivot at $19.33, with stronger resistance at $19.68 and $20.25.

The broader setup is still weak. The 7-day SMA is $19.50, while the 20-day and 50-day SMAs sit much higher at $23.97 and $26.99. The 12-day EMA at $21.41 and 26-day EMA at $23.82 point to the same conclusion: price remains below the main trend markers, so the burden is on buyers to show the move can stabilize.

Momentum is stretched, but not repaired

The RSI at 31.04 shows the stock is close to oversold territory, but that alone does not reverse the trend. MACD is negative at -2.4164, and the histogram is essentially flat at -0.0000, which suggests weak momentum rather than a confirmed turn.

The stochastic readings are also low, with %K at 6.91 and %D at 5.53. That fits a stock under pressure rather than one that has already reclaimed control.

Volatility and volume leave room for swings

Bollinger positioning is the main constructive element in the data. HIMS is near the lower band at $16.69, and %B at 0.1671 shows price sitting close to the bottom of the recent volatility range. ATR(14) is $2.12, which means the stock can still move sharply in either direction.

Volume does not point to panic. The 24-hour volume of $954,635 was 0.60x the 5-day average, which is more consistent with a low-volume pullback than heavy liquidation. That leaves open the possibility of a bounce, but not a confirmed trend change.

Derivatives data shows positioning, not certainty

Binance Futures data is tilted long, but it should be read carefully. The 8-hour funding rate is 0.0000%, so the market is not showing a clear premium for either side. Global Binance accounts were 66.3% long versus 33.7% short, and top-trader accounts were 68.4% long versus 31.6% short at the reported observation times. The taker buy/sell ratio of 1.5881 also shows more aggressive buying than selling.

Even so, these ratios describe Binance cohorts in the futures market, not retail versus institutional investors, and they do not guarantee a near-term move. They do show that futures participants are leaning long while price still trades below the main moving averages.

Analyst updates were split after the quarterly report

The analyst revisions do not point in one direction. Morgan Stanley’s Craig Hettenbach cut the target to $25 from $28 and kept an Equal-Weight rating on November 10, 2026. Jefferies lowered its target to $24 from $31 and kept a Hold rating on the same date. On the other side, Canaccord Genuity’s Maria Ripps reiterated Buy and left the target at $40 after the November 9 quarterly report.

That spread matters because it shows a wide gap in how the post-report setup is being valued. The lower targets reflect caution, while the $40 target leaves room for a much stronger rerating if execution improves. The supplied reports do not provide a consensus target, so this should be read as a divided analyst view rather than a single market message.

Levels to watch

For the short term, $18.76 is the first level to defend. If that gives way, $18.41 becomes the next support zone . On the upside, $19.33 is the first hurdle, followed by $19.68 and then $20.25.

The stock would need to reclaim the pivot cluster and start holding above the 7-day average before the technical picture improves materially. Until then, the evidence favors a cautious read: oversold conditions exist, but the trend has not yet turned.


Read More